The aim of the present study was to verify the feasibility of cryopreserving testicular tissue during the first diagnostic biopsy and then using thawed sperm to inseminate the partner's oocytes. The expected advantages are: (i) minimal risk of not having spermatozoa available at the time of intracytoplasmic sperm injection; (ii) no repeated surgical interventions, and (iii) programming the treatment cycle at the couple's convenience.Between May 1996 and May 1998, 64 azoospermic patients underwent investigative testicular biopsy combined with cryopreservation of spermatozoa which were retrieved in a simultaneously examined fresh sample. Testicular tissue cryopreservation was carried out in 43 cases (67\%) for later intracytoplasmic sperm injection attempts.In all, 23 couples underwent 26 assisted conception cycles; the fertilization rate was 64\% with spermatozoa (139/218, 24 cycles), 40\% with round spermatids (2/5, 1 cycle), and 69\% with elongated spermatids (9/13, 1 cycle). The embryo cleavage rate was 84\%. The mean number of embryos replaced in 24 patients was 2.7 +/- 0.7. In 2 cases, embryo quality was very poor, and they were not transferred to the patients. Eight clinical pregnancies resulted (35\%/patient and 33\%/transferred cycle) with an implantation rate of 14.1\%; 2 patients have already delivered and 6 pregnancies are ongoing normally.Testicular tissue cryopreservation during the first diagnostic biopsy is an alternative to repeated surgical interventions. Patients can initiate an ovarian stimulation cycle, confident of having spermatozoa available. Moreover, since only one straw is routinely used for each intracytoplasmic sperm injection cycle, the frozen tissue remains as a sperm source for multiple attempts.

Testicular sperm extraction combined with cryopreservation of testicular tissue in the treatment of azoospermia.

TROMBETTA, CARLO;LIGUORI, GIOVANNI;BELGRANO, Emanuele;
2000-01-01

Abstract

The aim of the present study was to verify the feasibility of cryopreserving testicular tissue during the first diagnostic biopsy and then using thawed sperm to inseminate the partner's oocytes. The expected advantages are: (i) minimal risk of not having spermatozoa available at the time of intracytoplasmic sperm injection; (ii) no repeated surgical interventions, and (iii) programming the treatment cycle at the couple's convenience.Between May 1996 and May 1998, 64 azoospermic patients underwent investigative testicular biopsy combined with cryopreservation of spermatozoa which were retrieved in a simultaneously examined fresh sample. Testicular tissue cryopreservation was carried out in 43 cases (67\%) for later intracytoplasmic sperm injection attempts.In all, 23 couples underwent 26 assisted conception cycles; the fertilization rate was 64\% with spermatozoa (139/218, 24 cycles), 40\% with round spermatids (2/5, 1 cycle), and 69\% with elongated spermatids (9/13, 1 cycle). The embryo cleavage rate was 84\%. The mean number of embryos replaced in 24 patients was 2.7 +/- 0.7. In 2 cases, embryo quality was very poor, and they were not transferred to the patients. Eight clinical pregnancies resulted (35\%/patient and 33\%/transferred cycle) with an implantation rate of 14.1\%; 2 patients have already delivered and 6 pregnancies are ongoing normally.Testicular tissue cryopreservation during the first diagnostic biopsy is an alternative to repeated surgical interventions. Patients can initiate an ovarian stimulation cycle, confident of having spermatozoa available. Moreover, since only one straw is routinely used for each intracytoplasmic sperm injection cycle, the frozen tissue remains as a sperm source for multiple attempts.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/2546968
 Avviso

Registrazione in corso di verifica.
La registrazione di questo prodotto non è ancora stata validata in ArTS.

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 3
social impact